CN107522777A - 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 - Google Patents
用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 Download PDFInfo
- Publication number
- CN107522777A CN107522777A CN201710824011.5A CN201710824011A CN107522777A CN 107522777 A CN107522777 A CN 107522777A CN 201710824011 A CN201710824011 A CN 201710824011A CN 107522777 A CN107522777 A CN 107522777A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- sequence
- amino acid
- protein
- crm197
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
动物品系 | 性别 | 体重 | 周龄 | 数量(只) |
Balb/c小鼠 | 雌性 | 18~22g | 6~8周 | 10 |
动物品系 | 性别 | 体重 | 周龄 | 数量(只) |
Balb/c小鼠 | 雌性 | 18~22g | 6~8周 | 80 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710824011.5A CN107522777B (zh) | 2017-09-13 | 2017-09-13 | 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710824011.5A CN107522777B (zh) | 2017-09-13 | 2017-09-13 | 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107522777A true CN107522777A (zh) | 2017-12-29 |
CN107522777B CN107522777B (zh) | 2021-06-11 |
Family
ID=60736684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710824011.5A Active CN107522777B (zh) | 2017-09-13 | 2017-09-13 | 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107522777B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114057844A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1838967A (zh) * | 2002-12-10 | 2006-09-27 | 洛伦蒂斯有限公司 | 稳定的免疫原性HBc嵌合体颗粒 |
CN101080239A (zh) * | 2003-02-21 | 2007-11-28 | 洛伦蒂斯有限公司 | 作为慢性肝炎治疗性疫苗的稳定化HBc嵌合体颗粒 |
CN101309699A (zh) * | 2005-08-31 | 2008-11-19 | 塞尔德克斯医疗有限公司 | 稳定化的病毒样颗粒和表位展示*** |
CN102807621A (zh) * | 2011-06-01 | 2012-12-05 | 厦门大学 | 包含白喉毒素无毒突变体crm197或其片段的融合蛋白 |
-
2017
- 2017-09-13 CN CN201710824011.5A patent/CN107522777B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1838967A (zh) * | 2002-12-10 | 2006-09-27 | 洛伦蒂斯有限公司 | 稳定的免疫原性HBc嵌合体颗粒 |
CN101080239A (zh) * | 2003-02-21 | 2007-11-28 | 洛伦蒂斯有限公司 | 作为慢性肝炎治疗性疫苗的稳定化HBc嵌合体颗粒 |
CN101309699A (zh) * | 2005-08-31 | 2008-11-19 | 塞尔德克斯医疗有限公司 | 稳定化的病毒样颗粒和表位展示*** |
CN102807621A (zh) * | 2011-06-01 | 2012-12-05 | 厦门大学 | 包含白喉毒素无毒突变体crm197或其片段的融合蛋白 |
US20140134199A1 (en) * | 2011-06-01 | 2014-05-15 | Xiamen Innovax Biotech Co., Ltd. | Fusion protein comprising diptheria toxin non-toxic mutant crm197 or fragment thereof |
Non-Patent Citations (3)
Title |
---|
M. HADIDA 等: "Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants", 《TROPICAL MEDICINE AND INTERNATIONAL HEALTH》 * |
MAWIEH HAMAD: "Universal vaccines: shifting to one for many or shooting too high too soon!", 《APMIS》 * |
李琼 等: "流感病毒M2e与白喉毒素无毒突变体CRM197融合蛋白的抗原性和免疫原性分析", 《病毒学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114057844A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848A (zh) * | 2020-08-07 | 2022-02-18 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057848B (zh) * | 2020-08-07 | 2023-11-21 | 清华大学 | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 |
CN114057847B (zh) * | 2020-08-07 | 2024-04-02 | 清华大学 | 一种预防新型冠状病毒covid-19的多肽、免疫原性偶联物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN107522777B (zh) | 2021-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107488218A (zh) | 一种多肽、免疫原性偶联物和流感疫苗 | |
AU570929B2 (en) | Broad spectrum influenza antisera | |
CN107488217A (zh) | 一种多肽、免疫原性偶联物和流感疫苗 | |
US4625015A (en) | Broad spectrum influenza antisera | |
US4981782A (en) | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use | |
CN105418738B (zh) | ***病毒a型抗原多肽、融合抗原多肽及疫苗 | |
US20120009212A1 (en) | Conjugates utilizing platform technology for stimulating immune response | |
CN113173977B (zh) | 一种双功能抗原、其制备方法及应用 | |
CN107522777A (zh) | 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途 | |
US20230330205A1 (en) | Norovirus vaccine | |
CN101879312B (zh) | 广谱型流感疫苗及其制备方法 | |
CN102397559B (zh) | 广谱型流感疫苗及其制备方法 | |
Heinimäki et al. | Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology | |
AU2010312300B2 (en) | Pharmaceutical composition for the treatment and prevention of a rhinovirus infection | |
NZ205924A (en) | Synthetic polypeptide: fragment of structural capsid protein; vaccine; method for diagnosis | |
CN106279379A (zh) | 一种免疫原HM4‑M2e及其制备方法与应用 | |
CN102775478B (zh) | ***病毒抗原多肽及疫苗 | |
Harmsen et al. | Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibility | |
CN114057850B (zh) | 一种预防新型冠状病毒covid-19的多肽、免疫原性偶联物及其用途 | |
JP2024502823A (ja) | 安定なコロナウィルスタンパク質およびそのワクチン組成物 | |
Kaushik et al. | Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid | |
Zou et al. | Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide | |
CN114057848B (zh) | 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途 | |
CN114053400B (zh) | 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法 | |
CN114057847B (zh) | 一种预防新型冠状病毒covid-19的多肽、免疫原性偶联物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant after: Hualan biological vaccine Co.,Ltd. Applicant after: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant after: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant after: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. Address before: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant before: HUALAN BIOLOGICAL BACTERIN Co.,Ltd. Applicant before: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant before: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant before: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200807 Address after: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant after: Hualan biological vaccine Co.,Ltd. Address before: No. 1, No. 1, No. 1, Hua Lan Boulevard a, Henan, Henan Applicant before: Hualan biological vaccine Co.,Ltd. Applicant before: HUALAN GENETIC ENGINEERING Co.,Ltd. Applicant before: HUALAN BIOLOGICAL ENGINEERING Inc. Applicant before: HUALAN BIOLOGICAL ENGINEERING TECHNOLOGY (BEIJING) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |